ViraCoat FFP2 Respirator Masks    -->please choose the option to Subscribe for in stock notification or further information      

COVID-Eliminating & Viricidal      

This next-generation ViraCoat FFP2 Mask has been scientifically demonstrated to have profound antiviral properties against SARS-CoV-2 (including new strains), Influenza (PR8 strain), and Bacteria (E. coli). 

• Distinctive green colour is easily identifiable and means you instantly know you are picking up a more effective piece of PPE.
• Lightweight — Weighs less than 6g.
• Reusable — Viricidal properties mean less-frequent replacement may be required throughout the day.
• Ergonomically shaped for maximum comfort and ease of use.
• Adjustable nose bridge to ensure an optimal seal.
• Individually wrapped and packaged in a box with instructions.
• FFP2 filtering efficiency: ՙ Filtering ≥94% of aerosols ՙ Total inward leakage <8%
• Certified to BS EN149:2001+A1:2009
• CE 0598
• UKCA 0120
• ISO 18184:2019 (Textiles – determination of antiviral activity in textile products)
• ISO 10993-1:2018 (Biological evaluation of medical devices safety, cytotoxicity, dermal & skin sensitisation)
• Head loop for comfort (designed at the request of medical staff)
• Folds flat with a protective five-layer construction
• High-quality, non-woven breathable fabric

Key features of Virucidal, Antiviral & Antimicrobial (Neutrapodal™) Technology.

•    Eliminates viruses to an efficacy of 99.9%within 5 minutes of contact.*
•    Infused into mask textile material under extreme pressure - creating an extremely durable and virtually     irreversible bond between the Neutrapodal™ coating and the mask material at the molecular level.
•    Protects against both viruses and bacteria.
•    Stringent, comprehensive safety reseach & development approvals.
•    All ViraCoat products are tested using live, current strains of virus and bacteria.
•    Tested as effective on all SARS-CoV-2 strains (Omicron (South Africa); Delta (India); Gamma (Brazil); Lambda         (Peru); Beta (South Africa); & Alpha (UK)), as well as Influenza strains PR8 and E. coli bacteria.